iQue® Cell Proliferation Kits
Cell Based Assays
Receive your quote directly from the manufacturer.
Excellent product. Great instrument for high-throughput studies.
Cell analysis
Great instrument, save my time while generate great data. The instrument is very user-friendly. It reads samples fast and allows high-throughput reads. If connected with automation it can screen fifty 384-well plates in 24 hours. Very useful for high throughput antibody primary screening and still works for smaller size of flow assays, Intellicyt is a powerful tool that provides rapid and cost effectively screening and profiling of disease, small molecule drug discovery or biologics discovery by cell based or bead-based assays. It provides user friendly software.
Review Date: 28 Mar 2025 | Sartorius Group
The iQue® Cell Proliferation Kit consists of a spectrally distinct proprietary fluorescent dye that is cell permeable. The Cell Proliferation Kits can be multiplexed with other iQue reagents in our reagents portfolio.
Key Benefits:
- Two dye options give you more ways to measure cell proliferation.
- No wash protocol, just add and read for fast, easily automated workflow.
- Multiplex with other iQue kits like QBeads® PlexScreen kits for richer content.
- Dyes are safe and non-toxic to you and the cells.
High Throughput Flow Assays using the MultiCyt Cell Proliferation Reagent Dye Panel: Multiplexing with Membrane Integrity, Cell Cycle, and Immunophenotyping Endpoints
This application note explains the principles behind the MultiCyt Cell Proliferation dyes. Their key advantages are demonstrated, including several examples that illustrate the value of multiplexing with other endpoints.
Advancing Therapeutic Antibody Discovery with Multiplexed Screening
Antibody-based therapeutics are the fastest growing and most successful therapeutic modality for treating diseases such as cancer, cardiovascular disease, autoimmune disorders and infectious disease.This whitepaper describes how the iQue Screener is used to perform multiplexed screens for antibody binding to either cell surface or to circulating target antigens. The whitepaper also discusses the use of the same platform to carry out high content assays to evaluate the effects of lead candidates in multiplexed cell based and secreted protein assays.
